News
During a cabinet meeting at the White House yesterday, Donald Trump demonstrated his lackluster understanding of percentages as he vowed to reduced drug prices by 1500%. If drug prices were reduced by ...
ORANGEBURG COUNTY, S.C. — Two brothers from North, South Carolina, are facing new drug charges, just weeks after they were initially arrested on similar offenses. “My deputies went out there last week ...
Donald Trump won’t stop lying about his dangerous plan to decrease drug prices in the stupidest way possible. “This is something that nobody else can do,” Trump said during a reception with members of ...
President Donald Trump made an outrageous claim about lowering the cost of prescription drugs during a meeting with members of Congress on Tuesday. On Tuesday, Trump claimed that he could lower drug ...
Donald Trump Flubs Math Problem While Bragging About Cutting Drug Prices ‘Unprecedented’: Trump Wins Supreme Court Ruling — Jackson Dissents Why don’t we bury all our power lines to prevent outages?
Endeavor BioMedicines Receives Orphan Drug Designation from the U.S. Food and Drug Administration and European Commission for Taladegib (ENV-101) for the Treatment of Idiopathic Pulmonary Fibrosis ...
SAN DIEGO--(BUSINESS WIRE)--Endeavor BioMedicines (“Endeavor”), a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients ...
Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designation to its cell therapy, MB-101. Get the strategy to turn September’s volatility into 10x trades → ...
A paramedic who tricked a woman into having an abortion by spiking her during sex has been sentenced to 10 years in prison. Stephen Doohan, 33, was married when he met the woman on holiday in Spain in ...
In an ongoing Phase 1 trial published in Nature Medicine, MB-101 was well-tolerated and 50% of patients achieved stable disease or better with two partial responses and two complete responses lasting ...
Aardvark’s IPO raised $94.2 million at $16/share; funds expected to support operations into 2027. HC Wainwright initiated coverage with Buy rating, sets $40 price forecast of AARD. See the trading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results